YBYusuf Baran

Yusuf Baran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yusuf Baran has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Policy Interface to Planetary Challenges: Emerging Trends in Science Diplomacy and Implications for Higher Education

    by Yusuf Baran, Ömer Cem Karacaoğlu, Abdulkadir Özkaya

    This study provides a comprehensive analysis of the evolution, thematic structure, and intellectual foundations of science diplomacy literature from 2000 to 2025. By integrating bibliometric analysis, topic modeling, and trend discovery, the research identified nine thematic clusters reflecting the conceptual richness and interdisciplinary nature of the field. The findings reveal a sharp increase in publication volume, high rates of international collaboration, and increasing emphasis on policy-relevant themes such as climate-informed knowledge production, sustainability governance, and biodiversity management. While topics such as international science diplomacy are declining, areas such as knowledge brokerage and climate adaptation are accelerating. The results highlight a paradigm shift toward science diplomacy as a strategic governance tool to address complex, cross-border challenges in the Anthropocene era. Moreover, this shift brings to the fore critical consequences for higher education, necessitating the internationalization of academic institutions and the design of curricula aimed at developing interdisciplinary competencies in future academics and policymakers. This study contributes to mapping the intellectual landscape of the field and provides valuable insights for future academic and policy-oriented engagement.

  • Open Access

    Determination of the therapeutic effects of apigenin on chronic myeloid leukemia stem cells; a mechanistic approach

    by Ali Ünal, Özge Göktepe, Melisa Çetinkaya, Yusuf Baran

    Aims: Chronic myeloid leukemia (CML) is a type of leukemia characterized by the Philadelphia (Ph) chromosome encoding the BCR-ABL protein. Significant success has been achieved in the treatment of CML with the development of agents that target this protein and inhibit its activity, but the resistance that develops in patients against these drugs limits absolute success. One of the main reasons for the resistance problem is the ineffectiveness of current therapies for CML stem cells. Apigenin (4',5,7- trihydroxyflavone) is a flavanoid found in various vegetables and fruits and has the effects of suppressing proliferation and inducing apoptosis in different cancer types. In this study, we aimed to determine the therapeutic potential of apigenin on K562 CML stem cells. Methods: The effects of apigenin on the proliferation of K562 CML stem cells were determined by an XTT cell proliferation assay. Apoptotic effects of apigenin on K562 CML stem cells were determined by changes in mitochondrial membrane potential (MZP), caspase-3 enzyme activity, and the Annexin-V method using flow cytometry. Results: The proliferation of K562 CML stem cells exposed to increasing doses of Apigenin (1-40 nM) for 48 hours decreased dose-dependently, and the IC50 value of Apigenin was calculated at 3 nM. Compared to the control group, an increase in caspase-3 enzyme activity was calculated in stem cells treated with apigenin at the same doses. Disruptions in the mitochondrial membrane potential of Apigenin-treated CML stem cells and Annexin-V assay results also showed that Apigenin dose-dependently induced apoptosis and caused significant increases in the apoptotic cell population. Conclusion: It was shown for the first time in this study that apigenin may have therapeutic effects on CML stem cells. It was determined that this effect of apigenin was achieved by triggering caspase-3 enzyme activity and disruptions in the mitochondrial membrane.

  • Investigation of Potential Anticarcinogenic Effects of Corilagin in Lung Cancer Cells

    by Cagla Rencuzogullari̇, Zeynep Birsu Ci̇nci̇n, Elif Sinem Ipli̇k, Yusuf Baran, Bedia Cakmakoglu


  • Open Access

    A minimally invasive transfer method of mesenchymal stem cells to the intact periodontal ligament of rat teeth: a preliminary study

    by Nisa Gül Amuk, Gökmen Kurt, Melis Kartal Yandim, Aysun Adan, Yusuf Baran

    The aim of this study was to introduce a minimally invasive procedure for mesenchymal stem cell (MSC) transfer into the intact periodontal ligament (PDL) of the molar teeth in rats. Ten 12-week-old Wistar albino rats were used for this preliminary study. MSCs were obtained from bones of two animals and were labeled with green fluorescent protein (GFP). Four animals were randomly selected for MSC injection, while 4 animals served as a control group. Samples were prepared for histological analysis, Cox-2 mRNA expression polymerase chain reaction analysis, and fluorescent microscopy evaluation. The number of total cells, number of osteoclastic cells, and Cox-2 mRNA expression levels of the periodontal tissue of teeth were calculated. The number of total cells was increased with MSC injections in PDL significantly (P < 0.001). The number of osteoclastic cells and Cox-2 mRNA expression were found to be similar for the two groups. GFP-labeled MSCs were observed with an expected luminescence on the smear samples of the PDL with transferred MSCs. The results of this preliminary study demonstrate successful evidence of transferring MSCs to intact FIX in a nonsurgical way and offer a minimally invasive procedure for transfer of MSCs to periodontal tissues.


  • Open Access

    PROTEASOME INHIBITOR BORTEZOMIB INCREASES RADIATION SENSITIVITY IN ANDROGEN INDEPENDENT HUMAN PROSTATE CANCER CELLS

    by Serdar Goktas, Ali U Ural, Yusuf Baran, Sertac Yazici, Emin Aydur, Ferit Avcu, Aysel Pekel, Bahar Dirican, Murat Beyzadeoglu